Browse current and previous editions of Switzer Report
Led by Wall Street, the Aussie share market hit a record high at the end of January. Our Switzer model portfolios followed suit and recorded solid gains for the month, outperforming the benchmark index. In this article, I look at how they’ve performed so far this year.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains why he believes Corporate Travel Management Ltd (CTD) is an ADD to an investor’s portfolio.
Here are two mining services companies I think have good potential to rise from here – one larger business, with a lot of work outside Australia, and the other (one-tenth the size) mainly confined to its home state of Western Australia.
For the week ending Friday February 2, 2024, there were eight rating upgrades and 12 downgrades to ASX-listed companies by brokers covered daily by FNArena.
While the news doesn’t seem to add up, I’m happy to accept Wall Street’s take on a stronger-than-expected jobs report
In the past few months, I have become more bullish on small- and mid-cap retail stocks. Here are two online retailers to consider.
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, explains why he has a target price of $14 for Charter Hall.
Will ANZ succeed in its purchase of Suncorp Bank, and what is the outlook for insurance companies such as Suncorp? With Evolution Mining, should I cut now and bail? What is your exit price for RIO? Are there any good graphite stocks on the ASX?
Paul Rickard and Michael Wayne answers your questions on XRF, CBA, CHC & more
Is it time to buy lithium stocks? Jun Bei Liu says yes, but which ones?
I’m going long lithium, backing billionaires like Elon Musk and Gina Rinehart, even though I know I might have to wait a long time to get the big pay-off.
I’m a great believer in term deposits in an investor’s portfolios (if the rate and term is right) because term deposits are one of the few investments where retail investors get better rates than wholesale investors. This is for two reasons, which I explain here today.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains was he sees Resmed (RMD) as an ADD to an investor’s portfolio.
What happens when investors lose faith in a market darling? I’m taking a look at three classic scenarios.
While new listings are quiet now, improving market conditions could unleash more floats in the second half of this year. Here are my eight top tips with IPO investing.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.